Fineotex Chemical Ltd

- No explicit mention of any immediate or planned fundraising through debt or equity in the transcript. - The company highlighted having a healthy cash balance of over INR360 crores after INR117 crores in capex over the last 16 months. - Sanjay Tibrewala emphasized that the company is very cash disciplined and uses internal accruals for investments. - For inorganic acquisitions, the company is prepared to use its cash reserves rather than raising new funds. - The recent expansion and acquisition activities have been funded through internal accruals and prior fundraises. - No direct indication of fresh equity or debt issuance during the current financial year was provided. - If any inorganic deal happens, it may be funded through available cash or borrowing but no formal plan announced yet.

- The company has completed significant capital expenditure (capex) of INR117 crores over the last 16 months, commissioning a new facility with Phase 1 capacity of 15,000 tons, totaling 120,000 tons fungible capacity for multiple product lines (Page 9, 5, 9). - The expansion was done within cost limits and timelines, with a focus on operational readiness and quality (Page 9). - No current specific new capex announced as of August 2025, but the company remains focused on both organic and inorganic growth strategies, including strategic investments in R&D, market expansion, and selective acquisitions aligned with its long-term vision (Page 4). - They maintain a strong cash balance of over INR360 crores post capex, available for future inorganic opportunities (Page 11). - The company continues to explore and advance acquisition discussions under NDA, signaling potential strategic investments or acquisitions in the near future (Pages 14, 11).

- Fineotex expects continued strong growth driven by technical textiles, FMCG, and specialty chemicals. - The company targets expanding its presence in over 70 countries with a diverse distributor network. - Their recently commissioned Ambernath plant increases capacity to ~120,000 tons, supporting volume growth. - Historical CAGR highlights strong growth: 28% top line and 22% revenue CAGR over 5 years. - Management is optimistic about returning to peak FMCG volumes by year-end. - Focus on gaining global approvals and entering new markets, especially in oil & gas specialty chemicals and water treatment. - Brand building and increased marketing spend aim to sustain long-term EBITDA margins of 18-20%, eventually returning to 24-25%. - Inorganic growth opportunities via acquisitions are under active consideration. - Overall, Fineotex is confident in sustained volume and revenue growth fueled by innovation, capacity expansion, and market diversification.

- Fineotex has demonstrated strong historical growth with a 5-year PAT CAGR over 50% and revenue CAGR around 22%. - Management is optimistic about volume recovery and expects to reach peak sales levels of last year by FY26-end. - EBITDA margins are targeted to return to 18%-20% for the medium term, with a potential to improve further to 24%-25% in longer term as external factors become favorable. - Expansion with the new Ambernath facility (120,000 tons capacity) is expected to support higher production and revenue growth. - Growing order book and new businesses, especially in specialty oils, hygiene/FMCG, and oil & gas sectors, are likely to contribute to better profitability. - Inorganic growth opportunities are being explored actively, which could further boost earnings. - Continued marketing investments for brand building are anticipated to stabilize, implying improved EBITDA margins ahead. - Overall, management is committed to delivering sustainable long-term value and expects improving earnings and profitability trends.

- Fineotex Chemical Limited has a healthy order book reflecting strong business performance and customer trust (Page 4). - Recent quarters have seen initiation of successful trial orders for big corporates, including tanker load orders in liquids (Page 10). - There is a growing pipeline of orders in water treatment and oil & gas sectors, both domestic and export markets (Page 4). - The company is actively engaging with global corporate customers, including those in the Middle East and Russia for oil specialty chemicals, showing positive traction (Page 11). - New plant capacity commissioned at Ambernath (15,000 tons capacity) supports scaling up production and order fulfillment (Page 5). - Despite some seasonal delays (e.g., AquaStrike mosquito product revenue expected in the near future), overall order flow remains strong and growing (Page 5). - The company expects positive updates on inorganic growth and order additions in the current financial year (Page 11).